期刊文献+

“药品说明书之外的用法”相关问题研究 被引量:11

Study on Relevant Issues of Drug Usage beyond Dispensatory
原文传递
导出
摘要 目的:为规范我国"药品说明书之外的用法"提供参考。方法:介绍"药品说明书之外的用法"的定义及引发的问题,分析美国有关"药品说明书之外的用法"的监管和研究进展。结果与结论:"药品说明书之外的用法"可能导致用药安全、药品监管、医疗保险、企业宣传等方面的一些问题。我国可借鉴美国针对"药品说明书之外的用法"的相关举措,通过建立监管机构、行业协会、医护人员三位一体的合作模式,来规范我国市场上"药品说明书之外的用法"的使用。 OBJECTIVE: To provide references for the standardization of drug usage beyond dispensatory in China. METHODS: The definition of drug usage beyond dispensatory was introduced as well as related cases caused by it. The relevant supervision and study progresses of drug usage beyond dispensatory in America were analyzed. RESULTS CONCLUSIONS: Drug usage beyond dispensatory may cause several problems, such as the safety of drug use, drug administration, health insurance and corporation propaganda. We should learn the relevant actions of America and standardize the utilization of drug usage beyond dispensatory in the market by establishing the trinity cooperation model of regulatory authority, industry associations and medical personnel.
作者 李延敏 杨悦
出处 《中国药房》 CAS CSCD 北大核心 2010年第37期3469-3471,共3页 China Pharmacy
关键词 药品说明书之外的用法 监管 研究 进展 Drug usage beyond dispensatory Supervision Study Progress
  • 相关文献

参考文献9

  • 1刘丽萍,陈玉玲,谢进,王依文,韩晋.关于没有经过许可或药品说明书以外用药问题的探讨[J].中国药房,2008,19(25):1935-1937. 被引量:38
  • 2张波,李大魁,杨晓.药品说明书之外的用法的若干问题及对策[J].中华风湿病学杂志,2004,8(8):451-453. 被引量:41
  • 3Federal Bureau of Investigation. Justice department announces largest health care fraud settlement in its history pfizer to pay $2.3 billion for fraudulent marketing[EB/ OL]. http ://www.tbi.gov/pressrel/pressrel09/justice_090209. htm.2009-09-02.2009-10-09.
  • 4Policy and Medicine. Allegan sues FDA to allow scientifically backed off label[EB/OL ].http://www.policymed. com/2OO9/lO/allegan-sues- fda-to-allow-scientificallybacked-off-label-promotion.html.2009-10-01.2009- 10-09.
  • 5FDA. Good reprint practices for the distribution of medicol journal articles and medical or scientific reference publications on unapproved new uses of approved drugs and approved or cleared medical devices[EB/OL ].http:// www.fda.gov/RegulatoryInformation/Guidances/ucm 125126.htm.2009-01.2009-10-09.
  • 6ASHE Re: Docket No. FDA-2008-DO0053, Draft guidance for industry on good reprint practices for the distribution of medical journal articles and medical or scientific reference publications on unapproved new uses of approved drugs and approved or cleared medical devices [EB/OL].http://www.ashp.org/sashp/docs/files/advocacy/ Written_comments_final.pdf.2008-04-21.2009-10-09.
  • 7ASHP. Re: CMS- 1413 -P, Medicare program ; Payment policies under the physician fee schedule and other revisions to part B for CY 2010, proposed rule[EB/OL]. http://www.ashp.org/DocLibrary/Advocacy/GAD/PPS_ Compendia_Comments_082809.pdf.2009-08-28.2009- 10-09.
  • 8ASHP. Pharmacist organization evaluates evidence for "Off-Label" medication use[EB/OL].http://www.ashp. org/import/news/pressreleases/pressrelease.aspx?id=497. 2008-10-08.2009-10-09.
  • 9FEBM. Cancer care providers, pharma, and insurers gather for FEBM' s "Off-Label Therapy" forum[EB/OL]. http ://www.thefebm.org/about/forum_followup.html. 2008-09-24.2009-10-09.

二级参考文献17

  • 1王庆利,彭健,胡晓敏.儿童用药物非临床安全性评价[J].中国新药与临床杂志,2005,24(2):161-165. 被引量:6
  • 2张波,李大魁,杨晓.药品说明书之外的用法的若干问题及对策[J].中华风湿病学杂志,2004,8(8):451-453. 被引量:41
  • 3倪韶青,寿洪初,王珏.关于儿童用药的问题及建议[J].中国医院药学杂志,2007,27(6):815-817. 被引量:43
  • 4Mckenie CA, Barnes CL, Boyd JA, et al. Unlabeled uses for approved drug. Pharmacist, 1993, 18: 49.
  • 5Mundy GB, Fleckenstein L, Mazzullo JM, et al. Current medical practice and the food and drug administration: some evidence for the existing gap. JAMA, 1974, 229: 1774.
  • 6American Society of Hospital Pharmacists. ASHP statement on the use of medications for unlabeled uses. Am J Hospital Pharm,1992, 49: 2006.
  • 7Torres A. The use of food and drug administration-approved medications for unlabeled (off-label) uses. Arch Dermatol, 1994,130: 32.
  • 8Drug Facts and Comparisons. Drug Facts and comparison.51th ed.St Louis: A Wolters Kluwer Company, 1997. 3491.
  • 9Drug Facts and Comparisons. Drug Facts and comparison. 57th ed. St Louis: A Wolters Kluwer Company, 2003. 1740.
  • 10Health Care Financing Administration. Medicare Carriers'manual. Section2050.5. Washington DC: U.S. Department of Health and Human Services, 1987 .

共引文献74

同被引文献164

引证文献11

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部